NIKKEI 225
39,341.54 -325.53 (-0.82%) HANG SENG
17,716.47 -373.46 (-2.06%) CRUDE OIL
81.89 +0.99 (+1.22%) GOLD FUTURES
2,338.40 +25.20 (+1.09%) DOW
39,164.06 +36.26 (+0.09%) Bitcoin GBP
48,580.54 +459.88 (+0.96%)
WTW Aug 2024 210.000 put
- Zacks
Here's Why Willis Towers (WTW) Stock is Worth Retaining
New business, strategic acquisitions, geographic diversification, solid customer retention levels and a strong capital position poise Willis Towers (WTW) for growth.
- GlobeNewswire
Cost of new drug development is key concern for life science as focus shifts to repurposing
LONDON, June 27, 2024 (GLOBE NEWSWIRE) -- 63% of life science companies believe the high cost of new drug development is among the emerging themes that will have the greatest negative impact on the sector in the next 3-5 years, according to Global life science risk report 2024 published today by WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company. This is leading to an increased focus on finding novel use cases for existing drugs, named by 66% as having a positive impact
- GlobeNewswire
WTW expands Financial Institutions team by adding three experts focused on broker-dealers and independent financial advisors
NEW YORK, June 25, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of three strategic new hires within the Financial Institutions and Professional Services industry division, which is part of Corporate Risk and Broking, North America (CRB NA). Bringing deep expertise within broker-dealers and independent financial advisors, the addition of Heather Mann, Larry Trombino, and Jeanette Younger will significantly b
